scispace - formally typeset
Open AccessJournal Article

Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

Charles Huggins, +1 more
- 01 Apr 1941 - 
- Vol. 1, Iss: 4, pp 293-297
Reads0
Chats0
TLDR
It is demonstrated that a marked rise in acid phosphatase in serum is associated with the appearance or spread of roentgenologically demonstrable skeletal metastases and implies dissemination of the primary tumor and thus is of unfavorable prognostic significance.
Abstract
Carcinoma of the prostate gland is peculiarly favorable for endocrine investigation since frequent serial observations of the activity of phosphatases in serum were found to provide objective indices of activity of the neo/~i~m when the enzymes were increased in amount above normal. In the present paper data are given for the values of serum phosphatases in carcinoma of the prostate and in normal men. We shall demonstrate that the acid phosphatase of serum is reduced in metastatic carcinoma of the prostate by decreasing the activity of androgens through castration or estrogenic injections and that this enzyme is increased by injecting androgens. We have been unable to find previous observations indicating any relationship of hormones to carcinoma of the prostate gland. An enzyme capable of hydrolyzing phosphoric esters was discovered by Grosser and Husler (4) in intestinal mucosa and kidney. Robison (16) found that this enzyme was particularly high in activity in growing bone and cartilage and that its activity was greatest at pH 9 to 9.5. This ~alkaline phosphatase," was found by Kay (9) to be increased in the serum in certain bone diseases including metastasis of neoplasms to bone and later work has shown that among these conditions is carcinoma of the prostate. Davies (3) and Bamann and Riedel (1) discovered that there occurs in the spleen and kidney of swine and cattle, in addition to the alkaline phosphatase, a phosphatase with an activity maximum at pH 4.8. An enzyme believed to be identical with this "acid phosphatase" was found by Kutscher and Wolbergs (11) to be present in very large amount in the human prostate gland. This finding of great activity of acid phosphatase in the prostate gland was confirmed and extended to include prostatic cancer by Gutman, Sproul, and Gutman (7). The serum of certain patients with disseminated prostatic carcinoma was found by Gutman and Gutman (6) and Barringer and Woodard (2) to exhibit increased acid phosphatase activity. Robinson, Gutman, and Gutman'~I5) summarized the acid phosphatase activity levels of 44 patients with carcinoma of the prostate. They concluded that a marked rise in acid phosphatase in serum is associated with the appearance or spread of roentgenologically demonstrable skeletal metastases and implies dissemination of the primary tumor and thus is of unfavorable prognostic significance. METttODS AND MATERIALS

read more

Citations
More filters
Journal ArticleDOI

Guilt by association: a historical perspective on Huggins, testosterone therapy, and prostate cancer.

TL;DR: Factors contributing to the persistence of the T-dependent model included dramatic effects of castration, continued use of androgen deprivation for treatment of PCa, an influential spokesperson (Huggins), groupthink (failure to acknowledge evidence inconsistent with the prevalent ideology), and an imprecise formulation of the model ("more T, more cancer growth").
Journal ArticleDOI

α-methylacyl-CoA racemase (P504S)/34βE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy

TL;DR: Evaluating the expression of AMACR in patients with prostate carcinoma after hormonal therapy and assessing its diagnostic utility in combination with p63 and high molecular weight cytokeratin (34betaE12) staining found it can be helpful in evaluating prostate specimens for the presence of residual or recurrent carcinoma following hormonal therapy for cancer.
Journal ArticleDOI

Differential antiproliferative activities of alpha- and gamma-interferon and tumor necrosis factor alone or in combinations against two prostate cancer xenografts transplanted in nude mice.

TL;DR: It is concluded that cytokine combination treatment may provide a new approach in the treatment of hormone‐escaped prostatic tumors with significant antiproliferative effects against the PC3 tumor, but not against the DU145 tumor.
Journal ArticleDOI

Current treatment strategies for castration-resistant prostate cancer.

TL;DR: Cabazitaxel and sipuleucel-T are now approved for use in metastatic CRPC by the US Food and Drug Administration and some are in phase III development.
Journal ArticleDOI

Inhibition of Akt pathways in the treatment of prostate cancer

TL;DR: Akt is a serine/threonine kinase mediating multiple intracellular pathways involved in prostate cancer (CaP) biology, and an increasing number of Akt inhibitors demonstrate activity against a wide range of cancers in preclinical studies.
Related Papers (5)